ETFs
T
TGTX
Tg Therapeutics Inc
56.04
+0.54+0.97%After Hours: 55.50 -0.54 -0.96%19:34 07/24 EDT
OPEN/PREV CLOSE56.01/55.50
TODAY RANGE53.86-56.45
VOL1.44M
MARKET CAP8.58B
52 WEEK RANGE25.28-59.30
AVG VOL (3M)2.40M
% TURNOVER0.94%
TURNOVER--
P/E (TTM)19.53
% RANGE4.67%
EPS(TTM)2.870
P/E(FORWARD)40.46
P/B14.71
BVPS3.809
DIVIDEND--
P/S14.12
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP7.94B
SHARES OUTSTANDING153.08M
NEXT EARNINGS08/03-08/07
FREE FLOAT141.64M
LOT SIZE1
EX-DATE04/30/2012
News
Press Releases
Financial Reports
Profile
Seeking Alpha·6d ago
Stay Bullish Despite The Rough Week: Aerospace, Finance, Biotech, And AI
TipRanks·07/17 16:32
TG Therapeutics Targets Myasthenia Gravis Growth With New BRIUMVI Trial
Reuters·07/14 09:33
TG THERAPEUTICS INC <TGTX.O>: JP MORGAN RAISES TARGET PRICE TO $65 FROM $46
TipRanks·07/13 13:37
TG Therapeutics (TGTX) Gets a Buy from H.C. Wainwright
Dow Jones·07/13 10:10
TG Therapeutics Is Maintained at Buy by HC Wainwright & Co.
Benzinga·07/13 09:59
HC Wainwright & Co. Maintains Buy on TG Therapeutics, Raises Price Target to $77
Dow Jones·07/07 14:34
TG Therapeutics Is Maintained at Underperform by B of A Securities
Dow Jones·07/07 14:34
TG Therapeutics Price Target Raised to $20.00/Share From $17.00 by B of A Securities
Same Industry
Name/Symbol
Change%
Price